SPC-raf transgenic mice develop multiple small disseminated lung tumours that partially abut another, whereas SPC-myc transgenic mice develop larger circumscribed tumours, i.e. with a well defined interface between aerated lung and tumour. This evidence concerns the gene SFTPC and neoplasm.